LONDON, UK / ACCESSWIRE / September 22, 2017 / Pro-Trader Daily takes a closer look at Global Medical REIT, Inc. (NYSE: GMRE) as the Company's stock will begin trading ex-dividend on September 25, 2017. In order to capture the dividend payout, investors must purchase the stock a day prior to the ex-dividend date (excluding weekend) that is by latest at the end of the trading session on September 22, 2017. Are you looking for research on dividend stocks, if so register with us now for your free membership at:

http://protraderdaily.com/register/

Today, PRO-TD covers ex-dividend news on GMRE. Get our free coverage by signing up at:

http://protraderdaily.com/optin/?symbol=GMRE

Dividend Declared

On September 08, 2017, Global Medical announced that its Board of Directors authorized a $0.20 per share cash dividend to stockholders of record as of September 26, 2017, to be paid on October 09, 2017. This dividend represents the Company's Q3 2017 dividend payment to its stockholders.

Global Medical's indicated dividend represents a yield of 9.30%, which is more than double compared to the average dividend yield of 3.16% for the financial sector.

Dividend Insights

Global Medical has a dividend payout ratio of 38%, which indicates that the Company distributes approximately $0.38 for every $1.00 earned. The dividend payout ratio reflects how much amount a company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, and/or to add to its cash reserves.

According to analysts' estimates, Global Medical is forecasted to report earnings of $0.13 for the next year compared to the Company's annualized dividend of $0.80. Global Medical is a Real Estate Investment Trust (REIT) which is structured by law to distribute at least 90% of earnings. Moreover, since REITs generate income from owning portfolios of investment real estate, they are likely to have higher depreciation charges.

Since depreciation is a non-cash charge, it does not directly impact the ability of dividend the Companies can distribute. For this reason, Fund from Operations (FFO) is calculated by adding depreciation and amortization to earnings and subtracting any gains on sales which provides a better picture of any company's profitability and capacity to pay and to sustain dividends. For instance, Global Medical's net loss for the three months ended June 30, 2017, was $0.6 million, or $0.04 per share. The Company's quarterly FFO per share was $0.10. Global Medical's quarterly normalized adjusted funds from operations per share grew to $0.16 compared to $0.02 for Q2 2016.

Global Medical's cash and cash equivalents balance was $12.0 million as of June 30, 2017, compared to $19.7 million as of December 31, 2016. The Company's gross investment in real estate as of June 30, 2017, was $355.1 million compared to $206.6 million as of December 31, 2016. The Company's strong financial position indicates its ability to absorb any fluctuations in earnings and cash flow and to sustain its dividend distribution for a long period.

Recent Development for Global Medical

On September 18, 2017, Global Medical announced that it has closed on the issuance of 3,105,000 shares of its Series A Cumulative Redeemable Preferred Stock, $0.001 par value per share, inclusive of 405,000 shares of Series A Preferred Stock issued in connection with the underwriters' exercise of their over-allotment option, raising aggregate net proceeds of approximately $75 million, after deducting underwriting discounts and commissions and estimated offering expenses paid or payable by the Company. Global Medical intends to use the net proceeds from this offering for general corporate purposes, which may include funding new acquisitions and repaying indebtedness.

The Series A Preferred Stock has an initial liquidation preference of $25 per share. The Company expects trading of the Series A Preferred Stock on the New York Stock Exchange to commence on October 16, 2017, under the symbol "GMRE PrA".

About Global Medical

Global Medical is a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share. The Company intends to produce increasing, reliable rental revenue by expanding its portfolio and leasing each of its healthcare facilities to market-leading operators under a long-term triple-net lease. The Company's management team has significant healthcare, real estate, and public REIT experience and has long-established relationships with a wide range of healthcare providers.

Stock Performance

Global Medical REIT's share price finished yesterday's trading session at $8.83, rising 1.26%. A total volume of 159.22 thousand shares have exchanged hands. The Company's stock price advanced 5.62% in the previous one month and 5.37% in the past six months. Shares of the Company have a dividend yield of 9.06%. The stock currently has a market cap of $194.17 million.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter-holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily